OpenURL Connection Search

Select item for more details and to access through your institution.

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions.
Published in:
Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01058-6
By:
- Mata, Douglas A.;
- Benhamida, Jamal K.;
- Lin, Andrew L.;
- Vanderbilt, Chad M.;
- Yang, Soo-Ryum;
- Villafania, Liliana B.;
- Ferguson, Donna C.;
- Jonsson, Philip;
- Miller, Alexandra M.;
- Tabar, Viviane;
- Brennan, Cameron W.;
- Moss, Nelson S.;
- Sill, Martin;
- Benayed, Ryma;
- Mellinghoff, Ingo K.;
- Rosenblum, Marc K.;
- Arcila, Maria E.;
- Ladanyi, Marc;
- Bale, Tejus A.
Publication type:
Article
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34109-8
By:
- Murciano-Goroff, Yonina R.;
- Schram, Alison M.;
- Rosen, Ezra Y.;
- Won, Helen;
- Gong, Yixiao;
- Noronha, Anne Marie;
- Janjigian, Yelena Y.;
- Stadler, Zsofia K.;
- Chang, Jason C.;
- Yang, Soo-Ryum;
- Mandelker, Diana;
- Offit, Kenneth;
- Berger, Michael F.;
- Donoghue, Mark T. A.;
- Bandlamudi, Chaitanya;
- Drilon, Alexander
Publication type:
Article
RET -Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.
Published in:
Cancers, 2023, v. 15, n. 16, p. 4146, doi. 10.3390/cancers15164146
By:
- Desilets, Antoine;
- Repetto, Matteo;
- Yang, Soo-Ryum;
- Sherman, Eric J.;
- Drilon, Alexander
Publication type:
Article
Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 12, p. 7973, doi. 10.1245/s10434-024-16004-2
By:
- Offin, Michael;
- Aguirre, Nicole;
- Yang, Soo Ryum;
- Sauter, Jennifer L.;
- Karagkounis, Georgios;
- Mohamed, Mostafa;
- Cercek, Andrea;
- Kundra, Ritika;
- Zhang, Yanming;
- Wang, Hui Mei;
- Morris, Marty P.;
- Ladanyi, Marc;
- Nash, Garrett M.;
- Zauderer, Marjorie G.
Publication type:
Article
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.
Published in:
British Journal of Cancer, 2024, v. 131, n. 3, p. 601, doi. 10.1038/s41416-024-02760-1
By:
- Roa, Paola;
- Foglizzo, Valentina;
- Harada, Guilherme;
- Repetto, Matteo;
- Kulick, Amanda;
- de Stanchina, Elisa;
- de Marchena, Michelle;
- Auwardt, Supipi;
- Sayed Ahmed, Shaza;
- Bremer, Nicole Virginia;
- Yang, Soo-Ryum;
- Feng, Yangbo;
- Zhou, Chao;
- Kong, Norman;
- Liang, Ruixia;
- Xu, Haipeng;
- Zhang, Bin;
- Bardelli, Alberto;
- Toska, Eneda;
- Ventura, Andrea
Publication type:
Article
Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
Published in:
Cancer Cytopathology, 2020, v. 128, n. 1, p. 43, doi. 10.1002/cncy.22205
By:
- Yang, Soo‐Ryum;
- Mooney, Kelly L.;
- Libiran, Paolo;
- Jones, Carol D.;
- Joshi, Rohan;
- Lau, Hubert D.;
- Stehr, Henning;
- Berry, Gerald J.;
- Zehnder, James L.;
- Long, Steven R.;
- Kong, Christina S.;
- Kunder, Christian A.
Publication type:
Article
Teaching and learning FNA biopsy: An update for the modern audience.
Published in:
Cancer Cytopathology, 2019, v. 127, n. 10, p. 615, doi. 10.1002/cncy.22169
By:
- Yang, Soo‐Ryum;
- Ljung, Britt‐Marie
Publication type:
Article

Found: 7

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions.

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.

RET -Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.

Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors.

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.

Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.

Teaching and learning FNA biopsy: An update for the modern audience.